Literature DB >> 1459739

Cancer-cell traffic in the liver. I. Growth kinetics of cancer cells after portal-vein delivery.

E Barbera-Guillem1, I Smith, L Weiss.   

Abstract

Following the intrasplenic injection of B16F10 melanoma cells into mice, at first single cells, and later multicellular tumor foci were observed at different times in the liver. Cell numbers and tumor volumes were determined over the next 12 days, by confocal microscopy of thick liver sections. Fifteen minutes after injection, approximately 20% of the melanoma cells were identified in the liver microvasculature; after 48 hr, only 0.68% of these retained morphologic integrity; by 5 days only 0.13% of the originally detected cells incorporated BUdR; and, by 12 days, these subsequently grew into tumor nodules. Tumor volume changes with time were not exponential and, following a non-replicative period during the first 2 1/2 days, the volume doubling times increased from approximately 8 to 39 hr at 12 days. BUdR incorporation indicated that this was probably due to a diminishing proliferative fraction in the cancer-cell population. When animals were killed at 12 days, tumor foci were centered on the liver sinusoids and appeared to represent expansive growth of arrested cells, with no evidence of parenchymal invasion by migrating cancer cells, in spite of the absence of a subendothelial basement membrane. Our direct observations indicate that, in this model system, the post-delivery phase of hepatic colonization is characterized by high levels of inefficiency with respect to cancer-cell survival, growth and extravasation.

Entities:  

Mesh:

Year:  1992        PMID: 1459739     DOI: 10.1002/ijc.2910520624

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Deformation-driven destruction of cancer cells in the microvasculature.

Authors:  L Weiss
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

2.  Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.

Authors:  Dipak Panigrahy; Matthew L Edin; Craig R Lee; Sui Huang; Diane R Bielenberg; Catherine E Butterfield; Carmen M Barnés; Akiko Mammoto; Tadanori Mammoto; Ayala Luria; Ofra Benny; Deviney M Chaponis; Andrew C Dudley; Emily R Greene; Jo-Anne Vergilio; Giorgio Pietramaggiori; Sandra S Scherer-Pietramaggiori; Sarah M Short; Meetu Seth; Fred B Lih; Kenneth B Tomer; Jun Yang; Reto A Schwendener; Bruce D Hammock; John R Falck; Vijaya L Manthati; Donald E Ingber; Arja Kaipainen; Patricia A D'Amore; Mark W Kieran; Darryl C Zeldin
Journal:  J Clin Invest       Date:  2011-12-19       Impact factor: 14.808

3.  An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.

Authors:  Ofra Benny; Ofer Fainaru; Avner Adini; Flavia Cassiola; Lauren Bazinet; Irit Adini; Elke Pravda; Yaakov Nahmias; Samir Koirala; Gabriel Corfas; Robert J D'Amato; Judah Folkman
Journal:  Nat Biotechnol       Date:  2008-06-29       Impact factor: 54.908

Review 4.  Stepping out of the flow: capillary extravasation in cancer metastasis.

Authors:  Fayth L Miles; Freddie L Pruitt; Kenneth L van Golen; Carlton R Cooper
Journal:  Clin Exp Metastasis       Date:  2007-09-29       Impact factor: 5.150

5.  Implantation of human colorectal carcinoma cells in the liver studied by in vivo fluorescence videomicroscopy.

Authors:  S Ishii; T Mizoi; K Kawano; O Cay; P Thomas; A Nachman; R Ford; Y Shoji; J B Kruskal; G Steele; J M Jessup
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

6.  Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.

Authors:  Friedrich Foerster; Sebastian Boegel; Rosario Heck; Geetha Pickert; Nina Rüssel; Sebastian Rosigkeit; Matthias Bros; Stephanie Strobl; Leonard Kaps; Misbah Aslam; Mustafa Diken; John Castle; Ugur Sahin; Andrea Tuettenberg; Ernesto Bockamp; Detlef Schuppan
Journal:  Oncoimmunology       Date:  2017-12-26       Impact factor: 8.110

Review 7.  Immunological Regulation of Vascular Inflammation During Cancer Metastasis.

Authors:  Sheri A C McDowell; Daniela F Quail
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.